Citation Impact
Citing Papers
The gut microbiota and host health: a new clinical frontier
2015 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Molecular mechanisms and clinical management of cancer bone metastasis
2020
New trends in photobiology
1991
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Cancer burden in the year 2000. The global picture
2001 Standout
Hyperthermia in combined treatment of cancer
2002 Standout
Cancer to bone: a fatal attraction
2011 Standout
A Systematic Overview of Radiation Therapy Effects in Skeletal Metastases
2003
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Heating the patient: a promising approach?
2002 Standout
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
2003 Standout
Cancer Metastasis: Building a Framework
2006 Standout
Use of radionuclides for the palliation of bone metastases
2000
Guidelines on Bladder Cancer
2002
Head and neck cancer
2008 Standout
Percutaneous radiofrequency ablation of painful osseous metastases
2009
Macrophages in immunoregulation and therapeutics
2023 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
The cellular and molecular basis of hyperthermia
2002 Standout
Accelerated Radiotherapy, Carbogen, and Nicotinamide (ARCON) in the Treatment of Advanced Bladder Cancer: Mature Results of a Phase II Nonrandomized Study
2008
Relative biological effectiveness (RBE) values for proton beam therapy
2002 Standout
Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer.
1989
Long-term outcome of radiation-based conservation therapy for invasive bladder cancer
2007
The immune contexture in cancer prognosis and treatment
2017 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Emerging applications of the single cell gel electrophoresis (Comet) assay. I. Management of invasive transitional cell human bladder carcinoma. II. Fluorescent in situ hybridization Comets for the identification of damaged and repaired DNA sequences in individual cells
1998
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Bladder cancer
2016 Standout
A feasibility study of accelerated fractionation in radiotherapy of carcinoma of the urinary bladder
1997
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Radiation Dose–Volume Effects of the Urinary Bladder
2010
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.
1996
Cancer treatment and survivorship statistics, 2012
2012 Standout
Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial
2000
The Comet Assay for DNA Damage and Repair: Principles, Applications, and Limitations
2004 Standout
NCCN Task Force Report: Bone Health in Cancer Care
2009
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Current strategies in the management of hormone refractory prostate cancer
2003
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
2001 Standout
The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy
1995
Adjuvant Chemotherapy in T3 Carcinoma of the Bladder A Prospective Trial: Preliminary Report
1988
Erythropoietin increases hemoglobin in cancer patients during radiation therapy
1993
Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma
1999 Standout
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials.
1996
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
The relative cellular radiosensitivity of 30 human in vitro cell lines of different histological type to high LET 62.5 MeV (p → Be+) fast neutrons and 4 MeV photons
1994
Global cancer statistics in the year 2000
2001 Standout
Osteoblasts in prostate cancer metastasis to bone
2005
Quantification of late complications after radiation therapy
2001
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Radionuclide Therapy for Palliation of Pain Due to Osteoblastic Metastases
1998
Early changes in mouse urinary bladder function following fractionated X irradiation.
1992
The Role of Perioperative Chemotherapy in the Treatment of Urothelial Cancer
2006
Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data
2005 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Bladder Cancer
2020 Standout
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
The diagnosis, management, treatment and costs of prostate cancer in England and Wales.
1997
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Surgery versus radiotherapy for muscle invasive bladder cancer
2001
NCCN Task Force Report: Bone Health in Cancer Care
2013
The relative biological effectiveness of fractionated doses of fast neutrons (42 MeVd→Be) for normal tissues in the pig. I. Effects on the epidermis and dermal vascular/connective tissues
1988
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
2017
Guidelines for the management of thyroid cancer
2014 Standout
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
2002 Standout
THE CURRENT STATUS OF BLADDER PRESERVATION IN THE TREATMENT OF MUSCLE INVASIVE BLADDER CANCER
2000
Works of P.M. Quilty being referenced
A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer
1994
Cisplatin-containing chemotherapy in advanced head and neck cancer
1985
Results of Surgery Following Radical Radiotherapy for Invasive Bladder Cancer
1987
Results of Surgery Following Radical Radiotherapy for Invasive Bladder Cancer
1986
The influence of hemoglobin level on the regression and long term local control of transitional cell carcinoma of the bladder following photon irradiation
1986
A report of a randomized trial of d(15)+Be neutrons compared with megavoltage X ray therapy of bladder cancer
1985
The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy
1986
Results of a randomised study to evaluate influence of dose on morbidity in radiotherapy for bladder cancer
1985
An analysis of the radiation related morbidity observed in a randomized trial of neutron therapy for bladder cancer
1986
Prognostic indices for bladder cancer: An analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy
1986
Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control
1986
Treatment of Superficial (T1) Tumours of the Bladder by Radical Radiotherapy
1986